Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSL Behring
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female subjects of any age with a diagnosis of congenital fibrinogen deficiency.
Have received FCH (Haemocomplettan® P or RiaSTAP®) for treatment of bleeding, surgery or prophylaxis.
You may not be if
None
Clareo Health | An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency
